Patient | SIU Medicine

News

Notification of a Potential Data Security Incident

Dear Madam/Sir: The Southern Illinois University School of Medicine, (“SIU”) is providing notice pursuant to 815 ILCS 530/25 in connection with an incident that may have involved the personal information of certain Illinois residents. This notice will be supplemented, if necessary, with any new significant facts discovered subsequent to its submission. While SIU is notifying you of this incident, SIU does not waive any rights or defenses relating to the incident or this notice. NATURE OF THE INCIDENT AND CORRECTIVE ACTIONS TAKEN SIU recently discovered that an unknown, unauthorized third party

News

Alzheimer’s is more than just memory loss

Agitation and behavior changes can shape Alzheimer’s journey For many, memory loss is the hallmark sign of Alzheimer’s and dementia. But dementia does more than cloud memory. It can alter how people communicate, change their personality and attitude and lead to agitation or erratic behavior. Dementia can cause lack of judgement, a lack of empathy or difficulty in interpreting and communicating feelings. Neither the person nor the behavior is the problem—the issue often lies in an unmet need or emotion that the person is trying to communicate. There are many kinds of dementia. And in turn, each

Locations

Beth's Rx Café

825 N Rutledge St. Springfield, IL 62702

Get Directions

Mon - Fri: 7:00 am-3:00 pm

News

Want better sex? Check out these exercises.

Want better sex? For women, it starts with a healthy pelvic floor. A toned pelvic floor not only enhances sexual satisfaction but also prevents urinary incontinence, constipation and pelvic prolapse.

Trial

Internal Medicine

A Phase 1 Study of SGN-B6A in Advanced Solid Tumors

Active recruiting

This trial looks at a drug called sigvotatug vedotin (SGN-B6A) alone and with pembrolizumab, with or without chemotherapy, to find out whether it is safe for people who have solid tumors (NSCLC, HNSCC).

Trial

Urology

A Randomized Open-Label Phase 2/3 Study of BT8009 Monotherapy or in Combination in Participants with Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

Active recruiting

The main objective of the study is to measure how safe and effective BT8009 (zelenectide pevedotin) is when used alone and in combination with pembrolizumab in participants with locally advanced or metastatic urothelial cancer (UC).

Trial

Internal Medicine

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System vs. Sham for the Adjunctive Treatment of Hypertension

Active recruiting

The purpose of this clinical trial is to assess whether a medical device called the TIVUS System can lower high blood pressure in patients who are known to have hypertension.

Eligible patients include those who currently have a diagnosis of high blood pressure despite having taken or currently taking anti-hypertensive medications.

Trial

Internal Medicine

Radiance US GPS: The Global Paradise® System US Post Approval Study

Active recruiting

The purpose of this clinical study is to evaluate the real-world use of the Paradise Ultrasound Renal Denervation System indicated for patients who are unable to lower their blood pressure with lifestyle changes and medication.

Eligible patients include those who currently have a diagnosis of high blood pressure despite having taken or are currently taking anti-hypertensive medications.

Events

Car seat check | March 25, 2025

SIU Medicine and ThinkFirst invite you to have your car seats checked by nationally certified child passenger safety technicians. Please bring the child who will be riding in the car seat, the vehicle's owner's manual, and the car seat instruction manual, if possible. Car seat checks take approximately 30 minutes.

Events

Car seat check | March 25, 2025

Subscribe to Patient